Non-Cystic Fibrosis Bronchiectasis

CHMP Backs Brinsupri as First EU Therapy for Non‑Cystic Fibrosis Bronchiectasis

The positive opinion now goes to the European Commission for a final EU‑wide marketing‑authorisation decision.